Altered glycosylation of acetylcholinesterase in Creutzfeldt-Jakob disease

Journal of Neurochemistry

Volumn 96, Issue 1, 2006, Pages 97-104

  Silveyra, María Ximena ^a   Cuadrado Corrales, Natividad ^b   Marcos, Alberto ^c   Barquero, María Sagrario ^c   Rábano, Alberto ^d   Calero, Miguel ^b   Sáez Valero, Javier ^a  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

Author keywords

Acetylcholinesterase; Alzheimer's disease; Cerebrospinal fluid; Creutzfeldt Jakob disease; Glycosylation; Molecular form

Indexed keywords

ACETYLCHOLINESTERASE; LECTIN; PRION PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC VALUE; ENZYME ACTIVITY; ENZYME GLYCOSYLATION; FEMALE; HUMAN; HUMAN TISSUE; LECTIN BINDING; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; BRAIN; BRAIN LEVEL; CEREBROSPINAL FLUID; CHEMISTRY; ENZYMOLOGY; GLYCOSYLATION; METABOLISM; MIDDLE AGED; OCCIPITAL LOBE; PHYSIOLOGY;

ACETYLCHOLINESTERASE; AGED; ALZHEIMER DISEASE; BRAIN; BRAIN CHEMISTRY; CREUTZFELDT-JAKOB SYNDROME; FEMALE; GLYCOSYLATION; HUMANS; LECTINS; MALE; MIDDLE AGED; OCCIPITAL LOBE;

EID: 33644842309     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03514.x     Document Type: Article

References (44)

1. American Psychiatric Association 1994 Diagnostic and Statistical manual of mental disorders Washington D.C. American Psychiatric Association
2. Arendt T. 2000 Alzheimer's disease as a loss of differentiation control in a subset of neurons that retain immature features in the adult brain NeurobiolAging 21 783 796
3. Arendt T. Bruckner MK. Lange M. Bigl V. 1992 Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development - a study of molecular forms NeurochemInt 21 381 396
4. Atack JR. Perry EK. Bonham JR. Perry RH. Tomlinson BE. Blessed G. Fairbairn A. 1982 Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type: selective loss of the intermediate (10S) form NeurosciLett 40 199 204
5. Ermonval M. Mouillet-Richard S. Codogno P. Kellermann O. Botti J. 2003 Evolving views in prion glycosylation: functional and pathological implications Biochimie 85 33 45
6. Fodero LR. Sáez-Valero J. Barquero MS. Marcos A. McLean CA. Small DH. 2001 Wheat germ agglutinin-binding glycoproteins are decreased in Alzheimer's disease cerebrospinal fluid JNeurochem 79 1022 1026
7. Folstein MF. Folstein SE. McHugh PR. 1975 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician JPsychiatrRes 12 189 198
8. Guevara J. Espinosa B. Zenteno E. Vazguez L. Luna J. Perry G. Mena R. 1998 Altered glycosylation pattern of proteins in Alzheimer disease JNeuropatholExpNeurol 57 905 914
9. Hounsell EF. 2004 Prions in control of cell glycosylation BiochemJ 380 e5 e6
10. Hu W. Gray NW. Brimijoin S. 2003 Amyloid-beta increases acetylcholinesterase expression in neuroblastoma cells by reducing enzyme degradation JNeurochem 86 470 478
11. Inestrosa NC. Alvarez A. Perez CA. Moreno RD. Vicente M. Linker C. Casanueva OI. Soto C. Garrido J. 1996 Acetylcholinestearse accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme Neuron 16 881 891
12. Iqbal K. Somerville RA. Thompson CH. Wisniewski HM. 1985 Brain glutamate decarboxylase and cholinergic enzyme activities in scrapie JNeurolSci 67 345 350
13. Kanninen K. Goldsteins G. Auriola S. Alafuzoff I. Koistinaho J. 2004 Glycosylation changes in Alzheimer's disease as revealed by a proteomic approach NeurosciLett 367 235 240
14. Kitazume S. Tachida Y. Oka R. Shirotani K. Saido TC. Hashimoto Y. 2001 Alzheimer's beta-secretase, beta-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase ProcNatlAcadSciUSA 98 13 554 13 559
15. Layer PG. 1995 Nonclassical roles of cholinesterases in the embryonic brain and possible links to Alzheimer disease Alzheimer DisAssocDisordSuppl 9 29 36
16. Liu F. Iqbal K. Grundke-Iqbal I. Hart GW. Gong CX. 2004 O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease ProcNatlAcadSciUSA 101 10 804 10 809
17. Massoulié J. Pezzementi L. Bon S. Krejci E. Vallette FM. 1993 Molecular and cellular biology of cholinesterases ProgNeurobiol 41 31 91
18. McKhann G. Drachman D. Folstein M. Katzman R. Price D. Stadlan EM. 1984 Clinical diagnosis of Alzheimer's Disease. report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 939 944
19. Méflah K. Bernard S. Massoulié J. 1984 Interactions with lectins indicate differences in the carbohydrate composition of the membrane-bound enzymes acetylcholinesterase and 5′-nucleotidase in different cell types Biochimie 66 59 69
20. Melo JB. Agostinho P. Oliveira CR. 2003 Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid beta-peptide NeurosciRes 45 117 127
21. Mesulam MM. Geula C. Morán MA. 1987 Anatomy of cholinesterase inhibition in Alzheimer's disease, effect of physostigmine and tetrahydroaminoacridine on plaques and tangles AnnNeurol 22 683 691
22. Mirra SS. Gearing M. McKeel DW. Jr. Crain BJ. Hughes JP. van Belle G. Heyman A. 1994 Interlaboratory comparison of neuropathology assessments in Alzheimer's disease: a study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) JNeuropatholExpNeurol 53 303 315
23. Nielsen D. Gyllberg H. Ostlund P. Bergman T. Bedecs K. 2004 Increased levels of insulin and insulin-like growth factor-1 hybrid receptors and decreased glycosylation of the insulin receptor alpha- and beta-subunits in scrapie-infected neuroblastoma N2a cells BiochemJ 380 571 579
24. Otto M. Esselmann H. Schulz-Shaeffer W. et al. 2000 Decreased beta-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease Neurology 54 1099 1102
25. Rees T. Hammond PI. Soreq H. Younkin S. Brimijoin S. 2003 Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex NeurobiolAging 24 777 787
26. Robinson N. 1969 Creutzfeldt-Jakob's disease: a histochemical study Brain 92 581 588
27. Rubenstein R. Deng H. Race R. Ju W. Scalici C. Papini M. Rubenstein A. Kascsak R. Carp R. 1994 Scrapie strain infection in vitro induces changes in neuronal cells MolNeurobiol 8 129 138
28. Rudd PM. Endo T. Colominas C. et al. 1999 Glycosylation differences between the normal and pathogenic prion protein isoforms ProcNatl AcadSciUSA 96 13 044 13 049
29. Rudd PM. Merry AH. Wormald MR. Dwek RA. 2002 Glycosylation and prion protein CurrOpinStructBiol 12 578 586
30. Sáez-Valero J. Sberna G. McLean CL. Small D. H. 1997 Glycosylation of acetylcholinesterase as diagnostic marker for Alzheimer's disease Lancet 350 929
31. Sáez-Valero J. Sberna G. McLean CA. Small DH. 1999 Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease JNeurochem 72 1600 1608
32. Sáez-Valero J. Barquero MS. Marcos A. McLean CA. Small DH. 2000 Altered glycosylation of acetylcholinesterase in lumbar cerebrospinal fluid of patients with Alzheimer's disease JNeurolNeurosurgPsychiatry 69 664 667
33. Saxena A. Raveh L. Ashani Y. Doctor BP. 1997 Structure of glycan moieties responsible for the extended circulatory life time of fetal bovine serum acetylcholinesterase and equine serum butyrylcholinesterase Biochemistry 36 7481 7489
34. Sberna G. Sáez-Valero J. Beyreuther K. Masters CL. Small DH. 1997 The amyloid β-protein of Alzheimer's disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells JNeurochem 69 1177 1184
35. Sberna G. Sáez-Valero J. Li QX. Czech C. Beyreuther K. Masters CL. McLean CA. Small DH. 1998 Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the β-amyloid protein precursor of Alzheimer's disease JNeurochem 71 723 731
36. Small DH. Michaelson S. Sberna G. 1996 Non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer's disease NeurochemInt 28 453 483
37. Sorbi S. Antuono P. Amaducci L. 1980 Choline acetyltransferase and acetylcholinesterase abnormalities in senile dementia: importance of biochemical measurements in human post-mortem brain specimens ItalJNeurolSci 1 75 83
38. Soreq H. Seidman S. 2001 Acetylcholinesterase - new roles for an old actor NatRevNeurosci 2 294 302
39. Soreq H. Ben-Aziz R. Prody CA. et al. 1990 Molecular cloning and construction of the coding region for human acetylcholinesterase reveals a G+C-rich attenuating structure ProcNatl AcadSciUSA 87 9688 9692
40. Tomita S. Kirino Y. Suzuki T. 1998 Cleavage of Alzheimer's amyloid precursor protein (APP) by secretases occurs after O-glycosylation of APP in the protein secretory pathway JBiolChem 273 6277 6284
41. Velan B. Kronman C. Ordentlich A. Flashner Y. Leitner M. Cohen S. Shafferman A. 1993 N-glycosylation of human acetylcholinesterase: effects on activity, stability and biosynthesis BiochemJ 296 649 656
42. Vidal CJ. 1996 Glycosylation of cholinesterases and its alteration in some pathological states Recent ResDevNeurochem 1 37 54
43. World Health Organisation 2003 WHO manual for surveillance of human transmissible spongiform encephalopathies, including Creutzfeldt-Jakob disease Geneva, Switzerland WHO
44. Zerr I. Pocchiari M. Collins S. et al. 2000 Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease Neurology 55 811 815